Evaluation of a combination of herbs against raised blood sugar

Phase 2

• Conditions: Health Condition 1: E119- Type 2 diabetes mellitus without complicationsHealth Condition 2: E119- Type 2 diabetes mellitus without complications

• Registration Number: CTRI/2022/06/043069
• Lead Sponsor: IIT BH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 27 June 2022

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Willing to give consent to participate in the study.

2. Sex-Both male and female in between 30 years and 60 years age group.

3. Patients having classical symptoms of diabetes and unequivocal blood sugar elevation.

4. Fasting blood sugar >= 126 mg/dl and up to 250 mg/dl.

5. Postprandial blood >= 200 mg/dl and up to 350 mg/dl.

6. Patients with uncontrolled of blood sugar in spite adequate doses of OHDs.

7. Patients having complication of diabetic neuropathy.

8. Uncontrolled cases of Type-2 DM, those on Conventional treatment (not more than one year).

Exclusion Criteria

1. Patients in > 30 years and < 60 years age group.

2. Patients of IDDM or juvenile onset diabetes.

3. Patients of Type-2DM with severe grade blood glucose levels (fasting >200 mg/dl and PP > 350 mg/dl)

4. Patients of severe Diabetic complications such as cardiopathy, nephropathy, foot Gangrene etc and other endocrine disorders.

5. Pregnant and Lactating Mothers.

6. History of recurrent infections.

7. Patients on corticosteroid therapy.

8. Uncontrolled cases of Type-2 DM, those on Conventional treatment (more than one year).

9. Patient not willing to participate in the study or not in a position to give consent.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
changes observed after trial intervention in terms of Fasting and Postprandial blood Glucose; HbA1C% and Lipid Profile. <br/ ><br>Timepoint: at time registration - 0 month <br/ ><br>after 1st month <br/ ><br>after 2nd month <br/ ><br>after 3rd month

Secondary Outcome Measures

Name	Time	Method
subjective parameters - Polyuria, polyphagia,etc. <br/ ><br>Lipid profile, Inflammatory markers - IL-6, 4, CRPTimepoint: At time of registration - 0 month <br/ ><br>after 1st month <br/ ><br>after 2nd month <br/ ><br>after 3rd month